$27.43 - MRSN | Mersana Therapeutics, Inc. Common Stock

Mersana Therapeutics, Inc. Common Stock (MRSN)

Mersana Therapeutics, Inc. Common Stock

XNAS:MRSN

27.43

-0.40%

Ask

$27.99 - 100.00

Bid

$27.22 - 998.00

Low

$27.3

High

$27.58

Open

$27.55

Prev Close

$27.54

52W High

70.73

52W Low

5.21

Volume

34074

Avg Vol (3m)

122169

Float

3891141.97

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 06/28/2017

Primary Exchange: XNAS

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Phone: 617-498-0020

Address: 840 Memorial Drive

City: Cambridge

State: MA

Postal Code: 02139

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

102

P/E (TTM)

-1.950000

P/B (TTM)

-2.302900

Round Lot

100

Composit FIGI

BBG001CPSVF3

Share Class FIGI

BBG001TZ57P0

Share Class Shares Outstanding

4.99M

Weighted Shares Outstanding

4.99M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion